top
Search terms
Results 1 - 5 of 5 - ordered by :
Ejhf

[...]clinical trials of ‘anti-inflammatory’ therapies (such as anti-tumor necrosis factor-α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure ...

European Journal of Heart Failure, Heymans, Stephane, Hirsch, Emilio, Anker, Stefan D., Aukrust, Pal, Balligand, Jean‐Luc, Cohen‐Tervaert, Jan W., Drexler, Helmut, Filippatos, Gerasimos, Felix, ...

Date : 01/02/2009 Item size : 354817 bytes
Ehjournal

[...]in a recently completed large-scale clinical trial, 30% of patients with stable NYHA class II or III heart failure died during a mean follow-up period of less than 3 1/2 years; at the same time, ...

European Heart Journal, Wollert, Kai C, Drexler, Helmut

Date : 01/12/2003
Ehjournal

[...]in a recently completed large-scale clinical trial, 30% of patients with stable NYHA class II or III heart failure died during a mean follow-up period of less than 3 1/2 years; at the same time, ...

European Heart Journal, Wollert, Kai C, Drexler, Helmut

Date : 01/12/2003 Item size : 102862 bytes
Ehjournal

[...]in a recently completed large-scale clinical trial, 30% of patients with stable NYHA class II or III heart failure died during a mean follow-up period of less than 3 1/2 years; at the same time, ...

European Heart Journal, Wollert, Kai C, Drexler, Helmut

Date : 01/12/2003 Item size : 116069 bytes
Ejhf

[...]clinical trials of ‘anti-inflammatory’ therapies (such as anti-tumor necrosis factor-α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure ...

European Journal of Heart Failure, Heymans, Stephane, Hirsch, Emilio, Anker, Stefan D., Aukrust, Pal, Balligand, Jean‐Luc, Cohen‐Tervaert, Jan W., Drexler, Helmut, Filippatos, Gerasimos, Felix, ...

Date : 01/02/2009 Item size : 371733 bytes